Sweat Equity

There are genuine operational nuggets - creator deal evolution from flat fee to equity, the 10% commission-on-ad-spend structure, and the no-paid-ads-for-four-years strategy - but they're heavily diluted by personal anecdotes (Instagram origin story, goat cookout), lifestyle filler, and extended grilled cheese analogies. The signal-to-noise ratio is moderate at best.

“We have creators that have 500 followers. We just paid someone last month. Uh, she created $150,000 worth of, uh, orders with her one video. She has 500 followers. Literally 500 followers, and we just gave her 15 grand.”

“if you're signing a, you know, an A lister or a B lister. Yeah, you might be tapping into your equity pool. You know, normally it's 5 to 7%.”

The 'personal brand holding company' framing and 'community before brand' thesis are moderately interesting but not deeply argued; most of the episode recycles familiar takes (delegate to strengths, word of mouth is powerful, don't lose yourself building a company). There's little genuinely contrarian or first-principles reasoning.

“I think there's too many people or founders that go in and say, okay, I'm gonna launch a business, and I think people are gonna jump in to this community versus starting a community first and then building a brand off of your community.”

“Could I launch a tallow lotion right now and probably make 10 million bucks? Probably... Do I think these things are going to be around for another 100 years? Probably not.”

Devon and Albert are genuine practitioners who scaled Promix from sub-$500k to nine-plus figures, took a PE deal with Payne Schwartz, and built multiple adjacent businesses including a blood-testing startup growing faster than their early Olipop investment. They speak from lived operator experience rather than thought-leadership positioning, though the B2B applicability is narrow given the consumer brand context.

“I was an early investor in Olipop. This is growing faster. Like this is insanely, this is, it's insane.”

“We put it through a three week triple blind clinical trial, um, which went amazing. Um, 83% of people found digestive, um, release.”

The episode has several concrete data points - 83% triple-blind trial result, 500-follower creator generating $150k in orders paid $15k, 5-7% equity pool for A/B-lister influencers, 10% commission on ad spend via Tribe, 53 flights in three months - but key business metrics (Rhythm growth rate, Monroe pricing, total Promix revenue) are deliberately kept vague, and many product efficacy claims are anecdotal.

“she created $150,000 worth of, uh, orders with her one video. She has 500 followers. Literally 500 followers, and we just gave her 15 grand.”

“normally it's 5 to 7%. You have, you know, on the side for, you know, C suite execs or celebs you're bringing onto the brand”

The host asks some relevant follow-ups (deal structures, retail vs. DTC, influencer program mechanics) and occasionally introduces useful framing like 'unique mechanism,' but he frequently finishes the guests' sentences, agrees without challenge, and inserts sponsor ads at awkward junctures. There is no productive pushback or probing of contradictions, making it closer to a PR conversation than an interrogative one.

“Are you guys layering in the recommendations?”

“were you making a lot of the initial ads from your personal brand for D Bloat for Way Pro? Like, how did that kind of structure work initially?”